Scapular PNF and Activity Oriented Antiedema Proprioceptive Therapy on Shoulder Dysfunction Post Matectomy Lymphedema

Scapular Proprioceptive Neuromuscular Facilitation and Activity Oriented Antiedema Proprioceptive Therapy on Shoulder Dysfunction Post Matectomy Lymphedema

Ninety -three female patients suffering from shoulder dysfunction after breast cancer-related arm lymphedema, will National Cancer Institute (Cairo university) be randomly distributed into three groups equal in number.

In this study the patients will be randomly assigned into three groups (Thirty - one patient for each group):

Group (A):

Thirty-one patients will receive: Scapular PNF technique, Activity-Oriented Antiedema Proprioceptive Therapy (TAPA) technique for the affected shoulder region plus conventional physiotherapy program in a form of (Complex decongestive therapy (CDT).

Group (B):

Thirty-one patients will receive Scapular PNF technique for the affected shoulder region plus conventional physiotherapy program in a form of (Complex decongestive therapy (CDT))

Group (C):

Thirty-one patients will receive Activity-Oriented Antiedema Proprioceptive Therapy (TAPA) technique for the affected shoulder region plus conventional physiotherapy program in a form of (Complex decongestive therapy (CDT)

.

Inclusion Criteria:

The subject selection will be according to the following criteria:

• Age range between 40-60 years.
• Only female patients will participate in the study.
• All female patients diagnosed as unilateral breast cancer.
• All Female patients operated on for BC with BCRL in stages I and II.
• All female patients suffering from shoulder dysfunction after breast cancer-related arm lymphedema.
• All patients enrolled to the study will have their informed consent.

Exclusion Criteria:

The potential participants will be excluded if they meet one of the following criteria:

• Patients with health problems, diseases or dysfunctions that prevented them from participating in the intervention.
• Patients with bilateral lymphedema.
• Patients with previous primary lymphedema.
• Patients with metastasis.
• Patients whom staging was not possible due to atypical findings or poor image.
• Patients with active arm infection.